Goldman Sachs’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-838,362
| Closed | -$1.52M | – | 5069 |
|
|
2023
Q2 | $1.52M | Buy |
838,362
+22,166
| +3% | +$40.1K | ﹤0.01% | 3368 |
|
|
2023
Q1 | $1.08M | Sell |
816,196
-1,367,207
| -63% | -$1.8M | ﹤0.01% | 3615 |
|
|
2022
Q4 | $3.69M | Sell |
2,183,403
-3,646,268
| -63% | -$6.16M | ﹤0.01% | 2862 |
|
|
2022
Q3 | $10.8M | Buy |
5,829,671
+1,553,757
| +36% | +$2.87M | ﹤0.01% | 2067 |
|
|
2022
Q2 | $13.1M | Buy |
4,275,914
+2,163,503
| +102% | +$6.64M | ﹤0.01% | 1913 |
|
|
2022
Q1 | $15.3M | Buy |
+2,112,411
| New | +$15.3M | ﹤0.01% | 1904 |
|